Woodline Partners LP Sells 20,675 Shares of Align Technology, Inc. $ALGN

Key Points

• Woodline Partners LP reduced its stake in Align Technology, Inc. by 25.5%, selling 20,675 shares in the first quarter, which left them with 60,284 shares valued at approximately $9.58 million.
• Several institutional investors, including Vanguard Group Inc. and Ninety One UK Ltd., have increased their holdings, with Federated Hermes raising its stake by an impressive 510.3%.
• Align Technology's stock has a current market capitalization of $9.85 billion and reported a net margin of 11.04% along with a Q3 2025 guidance for earnings per share.

Woodline Partners LP lowered its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 25.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,284 shares of the medical equipment provider's stock after selling 20,675 shares during the period. Woodline Partners LP owned 0.08% of Align Technology worth $9,577,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of ALGN. Ninety One UK Ltd increased its stake in shares of Align Technology by 58.7% during the 1st quarter. Ninety One UK Ltd now owns 1,937,555 shares of the medical equipment provider's stock worth $307,800,000 after purchasing an additional 716,954 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of Align Technology by 510.3% during the 1st quarter. Federated Hermes Inc. now owns 707,514 shares of the medical equipment provider's stock worth $112,396,000 after purchasing an additional 591,588 shares during the last quarter. Mackenzie Financial Corp increased its stake in shares of Align Technology by 4,217.3% during the 1st quarter. Mackenzie Financial Corp now owns 426,205 shares of the medical equipment provider's stock worth $67,707,000 after purchasing an additional 416,333 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Align Technology by 104.2% during the 1st quarter. AQR Capital Management LLC now owns 404,310 shares of the medical equipment provider's stock worth $63,133,000 after purchasing an additional 206,308 shares during the last quarter. Finally, Citigroup Inc. increased its stake in shares of Align Technology by 333.4% during the 1st quarter. Citigroup Inc. now owns 256,492 shares of the medical equipment provider's stock worth $40,746,000 after purchasing an additional 197,317 shares during the last quarter. Hedge funds and other institutional investors own 88.43% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on ALGN shares. Zacks Research lowered shares of Align Technology from a "hold" rating to a "strong sell" rating in a research note on Monday, September 1st. Piper Sandler reduced their price objective on shares of Align Technology from $250.00 to $190.00 and set an "overweight" rating for the company in a research note on Thursday, July 31st. Wells Fargo & Company reduced their price objective on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a research note on Thursday, July 31st. Morgan Stanley reiterated an "equal weight" rating and issued a $154.00 price objective (down from $249.00) on shares of Align Technology in a research note on Thursday, July 31st. Finally, Mizuho set a $210.00 price objective on shares of Align Technology in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $215.00.

Align Technology Stock Up 0.5%

NASDAQ:ALGN traded up $0.69 during midday trading on Wednesday, hitting $132.51. The company had a trading volume of 168,726 shares, compared to its average volume of 1,221,355. Align Technology, Inc. has a 52-week low of $127.70 and a 52-week high of $262.87. The stock's fifty day moving average price is $158.09 and its 200-day moving average price is $169.27. The company has a market capitalization of $9.61 billion, a PE ratio of 22.35, a P/E/G ratio of 1.48 and a beta of 1.65.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter in the previous year, the company earned $2.41 earnings per share. The business's quarterly revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. As a group, research analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology declared that its Board of Directors has approved a stock repurchase plan on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 2% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its stock is undervalued.

Insider Activity at Align Technology

In other news, CEO Joseph M. Hogan acquired 7,576 shares of the stock in a transaction dated Friday, August 1st. The stock was purchased at an average cost of $131.49 per share, with a total value of $996,168.24. Following the completion of the purchase, the chief executive officer owned 184,945 shares in the company, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.66% of the company's stock.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.